These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 1796397)

  • 1. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O; Valentin S; Beck TC; Hedner U
    Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway.
    He R; Xiong S; He X; Liu F; Han J; Li J; He S
    Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
    Rapaport SI
    Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.
    Sandset PM; Larsen ML; Abildgaard U; Lindahl AK; Odegaard OR
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):425-33. PubMed ID: 1932528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of monoclonal antibody against human tissue factor pathway inhibitor on plasma coagulation time].
    Yang Y; He X; Li J; He S
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):297-300. PubMed ID: 9868079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor.
    Lindahl AK; Abildgaard U; Staalesen R
    Thromb Res; 1991 Oct; 64(2):155-68. PubMed ID: 1811336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.
    Sandset PM; Warn-Cramer BJ; Rao LV; Maki SL; Rapaport SI
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):708-12. PubMed ID: 1899482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
    Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
    Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VII and haemostasis.
    Osterud B
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):175-81. PubMed ID: 2130929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).
    Liu T; Scallan CD; Broze GJ; Patarroyo-White S; Pierce GF; Johnson KW
    Thromb Haemost; 2006 Jan; 95(1):68-76. PubMed ID: 16543964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical exercise enhances plasma levels of extrinsic pathway inhibitor (EPI).
    Hansen JB; Olsen JO; Osterud B
    Thromb Haemost; 1990 Aug; 64(1):124-6. PubMed ID: 2274917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extrinsic system.
    Triplett DA
    Clin Lab Med; 1984 Jun; 4(2):221-44. PubMed ID: 6388984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A.
    Erhardtsen E; Ezban M; Madsen MT; Diness V; Glazer S; Hedner U; Nordfang O
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):388-94. PubMed ID: 8589204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood.
    Abildgaard U; Lindahl AK; Sandset PM
    Haemostasis; 1991; 21(4):254-7. PubMed ID: 1794751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.